Director, Global Market Access

uniQure•,

4d•$205,000 - $265,000•Remote

About The Position

At uniQure, we are delivering on the promise of gene therapy and delivering hope for patients facing urgent unmet medical needs. Every role in our organization carries profound purpose; whether you're in research, operations, access, or support, your contributions impact patients. We're seeking passionate professionals who thrive in high-stakes environments, uphold rigorous quality standards, and share our relentless commitment to transforming the lives of patients. Join us in making the impossible possible, where your expertise becomes a catalyst for life-changing treatments. Reporting to the SVP, Market Access, this role responsible for developing market access strategies to support uniQure products across all global markets, with particular emphasis on Ex-US markets. The role requires deep understanding of reimbursement environment for both HTA and non-HTA markets, including pricing, value-based messaging and strategies, Most Favored Nation, dossier development, and International Reference Pricing etc. The Market Access team leads the development and execution of pricing, reimbursement, HEOR, Trade & Distribution, patient support services, and access strategies for uniQure’s rare disease/gene therapy portfolio. The team works in close partnership with Medical, Regulatory, Commercial, Legal, and cross-regional stakeholders to shape evidence generation, value communication, and access planning across the product lifecycle.

Requirements

Senior strategic market access leader with 8-10 years of pharma industry and/or consultancy experience, ideally within rare/orphan diseases and gene therapy.
Strong experience developing and executing access strategies across ex-US markets, including Europe, APAC, LATAM, the Middle East, and CIS.
Solid understanding of US payer engagement and reimbursement, with the ability to contribute strategically where needed.
Demonstrated ability to work cross-functionally and influence global pricing and reimbursement strategy.
Hands-on experience with IRP and associated systems, MFN, Global Value Dossiers, AMCP dossiers, and reimbursement submissions for HTA and non-HTA markets.
Excellent collaboration, communication, and stakeholder management skills in a global matrix environment.
Undergraduate degree (BS/BA) required - finance/economic/science background preferred.

Nice To Haves

Product launch experience in rare disease/gene therapy a significant plus.
Advanced degree preferred.

Responsibilities

Lead the development and execution of global pricing, reimbursement, and access strategies for rare disease and gene therapy programs, with a primary focus on ex-US markets.
Partner closely with regional, medical, regulatory, and commercial teams to align access strategy with product development, launch planning, and lifecycle management.
Drive access planning and reimbursement strategy across UK, Europe, APAC, LATAM, the Middle East, and CIS markets.
Manage and support IRP and MFN considerations, Global Value and AMCP dossiers, and reimbursement submissions for HTA and non-HTA markets.
Collaborate with internal stakeholders and external partners to ensure clear, consistent, and locally relevant value propositions across markets.
Support Ex-US distribution strategies to ensure product availability to select Ex-US markets.
Provide strategic input to governance forums and cross-functional decision-making processes to inform short- and medium-term global access strategy.
Support US market access engagement as needed, including contribution to payer value positioning and strategic input on US access considerations.
Translate market insights into practical recommendations that support launch readiness, access optimization, and global alignment.
Build and maintain strong internal and external relationships to advance access objectives in a highly matrixed, patient-focused environment.